Stem Cell Ophthalmology Treatment Study (SCOTS): improvement in serpiginous choroidopathy following autologous bone marrow derived stem cell treatment

We report results in a 77-year-old male patient with visual loss from long-standing serpiginous choroidopathy treated with bone marrow derived stem cells (BMSC) within the Stem Cell Ophthalmology Treatment Study (SCOTS). SCOTS is an Institutional Review Board approved clinical trial and the largest...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, Jeffrey N., Benes, Susan C., Levy, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090858/
https://www.ncbi.nlm.nih.gov/pubmed/27857759
http://dx.doi.org/10.4103/1673-5374.191229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090858/
https://www.ncbi.nlm.nih.gov/pubmed/27857759
http://dx.doi.org/10.4103/1673-5374.191229

Ejemplares similares